CTRI/2023/04/051727进行中(未招募)4 期
A Prospective, Multicentric, Single-arm Study to evaluate the effectiveness and safety in Patients undergoing Arthroscopic Anterior Cruciate Ligament (ACL) Reconstruction Procedure using Fixed Loop UHMWPE Suture Titanium Button and Titanium Interference Screw.
试验速览
- 阶段
- 4 期
- 状态
- 进行中(未招募)
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female subjects between 18 to 45 years of age.
- •2.Subjects with ACL injury with or without associated meniscus injuries requiring primary ACL reconstruction surgery.
- •3.Subject willing to give written informed consent to participate in the study.
排除标准
- •1.Subjects with Posterior Cruciate Ligament injury, and/or Collateral ligament injury.
- •2.Subjects with known hypersensitivity to titanium and/or UHMWPE suture.
- •3.Subjects with BMI =35 kg/m2
- •4.Subjects with a history of previous knee surgery
- •5.Subjects with the insufficient quantity or skeletally immature bone.
- •6.Subjects with active infection or blood supply limitations.
- •7.Subjects with pathological conditions of the bone or soft tissues that would impair secure fixation.
- •8.Subjects with conditions, which would limit the subject’s ability or willingness to restrict activities or follow directions during the healing period.
- •9.Subjects having any condition that could affect healing (Infections, regular use of Corticosteroids, Diabetes – HbA1C = 10).
- •10.Subjects with a history of heavy smoking ( > 20 cigarettes/day) within the last 6 months.
- •11.Subjects with a medical or physical condition that, in the opinion of the investigator, would preclude safe subject participation in the study.
- •12.Subjects who are pregnant or lactating at the time of screening
研究者
相似试验
招募中
4 期
A study to assess result after shoulder surgeryCTRI/2023/04/052027Healthium Medtech Limited
招募中
4 期
A study to assess result after shoulder surgeryCTRI/2023/07/055473Healthium Medtech Limited
尚未招募
4 期
The aim is to evaluate the safety and efficacy of MeRes100™ Sirolimus Eluting BioResorbable Vascular Scaffold in coronary artery disease patients.It enhances coronary luminal diameter in symptomatic ischemic heart disease, addressing de novo lesions in native coronary arteries.CTRI/2024/02/062438Meril Diagnostics Private Limited
撤回
3 期
A Prospective, Multi-Center, Single Arm Study of the Conor Cobalt Chromium Reservoir Based Stent (Nevo) with Sirolimus Elution in Native Coronary Artery Lesions (CP-07 protocol)atherosclerosisNL-OMON32462Conor Medsystems, LLC (maakt deel uit van Johnson & Johnson); contact persoon Emily Hergenreter40
已完成
Unknown
OFT-G1-301 StudyCongenital heart diseaseJPRN-jRCT1080224691TEIJIN LIMITED / TEIJIN PHARMA LIMITED30
